Related Experiment Video
Updated: Jun 27, 2025
05:25
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
2.5K
Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use
Nicoleta Mirela Blebea1, Andreea Iulia Pricopie2, Robert-Alexandru Vlad3
1Department of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, "Ovidius" University from Constanța, 900470 Constanța, Romania.
International Journal of Molecular Sciences
|April 27, 2024
Summary
Phytocannabinoids from cannabis, like cannabidiol (CBD) and tetrahydrocannabinol (THC), show diverse therapeutic potential. Further research is needed to fully understand their complex interactions and medicinal applications.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Neuroscience
Background:
- Phytocannabinoids are naturally occurring compounds from the Cannabis plant with significant pharmacological interest.
- Over one hundred cannabinoids have been identified, with cannabidiol (CBD) and tetrahydrocannabinol (THC) being the most researched.
Purpose of the Study:
- To provide a comprehensive review of phytocannabinoid pharmacological profiles and their biological system impacts.
- To explore the therapeutic potential of various phytocannabinoids, including CBD, THC, CBC, CBG, and CBN.
Main Methods:
- Literature review summarizing current research on phytocannabinoid pharmacology.
- Analysis of interactions between phytocannabinoids and the endocannabinoid system, ion channels, neurotransmitter receptors, and anti-oxidative pathways.
Main Results:
- CBD exhibits non-psychoactive anti-inflammatory, neuroprotective, and anxiolytic properties.
- THC demonstrates psychoactive effects with analgesic and antiemetic therapeutic potential.
- Other phytocannabinoids like CBC, CBG, and CBN also show promising pharmacological activities.
Conclusions:
- Phytocannabinoids interact with the endocannabinoid system and other biological pathways, offering potential for novel medical treatments.
- Significant information gaps remain, highlighting the need for continued research to fully harness the therapeutic potential of phytocannabinoids.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
187
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
187
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
237
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
237
01:25Analgesia and Pain Management
585
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
585
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
242
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
242
01:26Drug Administration and Therapy Phases: Overview
452
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
452
01:24Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K